Compare activation, injection completion feedback and primary container options for a defined drug program.
An autoinjector automates one or more injection steps using a defined mechanism, often a spring or an electromechanical drive. It should be selected around the intended drug, primary container, administration volume and user tasks. A spring-loaded injection pen and a manually operated dose-dial pen are not interchangeable descriptions. Before requesting a platform, document the expected viscosity range, temperature conditions, activation method and completion feedback. The usable dose and injection time need evidence from the intended configuration rather than a photograph or generic brochure. For B2B evaluation, also examine cap removal, accidental activation controls and the user’s response to an incomplete delivery. This page describes a development category, not an approved finished medicine. Availability, technical limits, testing responsibilities and sample conditions must be established in the project specification.
A prefilled-syringe autoinjector direction for a defined small-volume application. A 1 mL container target does not mean every project delivers the full nominal container capacity.
1 mL PFS target
Single administration; fill to define
An autoinjector direction built around a 2.25 mL prefilled-syringe target. The container format is seen in public industry platforms, but suitability still depends on the intended formulation.
2.25 mL PFS target
Fill and usable dose to define
A development brief for related product presentations that may use different fill volumes. The requirement is to understand how the mechanism handles the proposed stopper positions and dose volumes.
PFS format to confirm
Fixed delivered dose per configuration
An application-led autoinjector project in which formulation resistance is a central design input. The relevant viscosity range should be measured under conditions that reflect the intended product use.
Container and needle to define
Viscosity envelope to measure
A user-sequence direction emphasizing a short activation workflow. The term two-step describes a proposed interaction and does not by itself demonstrate intuitive or error-free operation.
PFS interface to define
Activation sequence to evaluate
An autoinjector direction using a distinct activation control. The button geometry, required force and any interlock should be reviewed in the context of the complete intended user sequence.
Container to define
Button and interlock to evaluate
An autoinjector project focused on the interaction between delivery and a protective needle feature. A shield needs a clearly defined state before, during and after the administration sequence.
Compatible PFS to confirm
Shield sequence to define
A feasibility direction for programs whose required volume exceeds their current handheld presentation. Larger volume can affect the container, drive, handling and time needed to complete delivery.
Volume above standard brief; assess
Volume and delivery time to validate
An autoinjector development direction for a specified biologic presentation. The formulation, container and delivery mechanism need to be evaluated together before performance can be promised.
Formulation and PFS to define
Volume and viscosity to assess
A powered delivery concept where motor, controls and energy supply become part of the mechanism specification. The development brief must define both normal operation and failure behavior.
Container and drive to define
Powered actuation; controls to evaluate
